76961-101Level 3
Rolvedon (eflapegrastim-xnst)
**Product type:** Human Prescription Drug
**Active ingredient:** EFLAPEGRASTIM
**Strength:** 13.2 mg/.6mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Spectrum Pharmaceuticals, Inc.
**Marketing category:** BLA (BLA761148)
**Pharmacologic class:** Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
GET
/api/v1/systems/ndc_fda/nodes/76961-101Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.